Genetically modified bone marrow cells halt mitral cell loss by modulating inflammation and protecting against DNA damage
Cell therapy is a promising strategy for tackling neurodegenerative diseases. The most outstanding results with this approach usually involve neuroprotection of damaged neurons at risk of death, but only with limited success. Current therapies are often based on the idea of “one gene, one disease, o...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2026-05-01
|
| Edice: | Journal of Tissue Engineering |
| On-line přístup: | https://doi.org/10.1177/20417314261442787 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
